Therapeutic testing in murine models of bacterial infection
Active Awarded
- Contract number
- 75N93026F00003
- Awardee
-
Pharmacology Discovery Services Taiwan, LTD. UEI MXP1NVQ8C1J8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $545,542
Award facts
- Opportunity
-
- A23 Solicitation number
- Contract value 24% obligated
-
- $545,542.00 Current, with exercised options
- $2,309,947.00 Potential, with all options
- Completion date 6% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Taiwan
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N93026F00003?
75N93026F00003 was awarded to Pharmacology Discovery Services Taiwan, LTD. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2026.
How much is contract 75N93026F00003 worth?
The government has obligated $545,542 on 75N93026F00003. Its potential value, with all options, is $2,309,947.
Is contract 75N93026F00003 an order under another contract?
Yes. 75N93026F00003 is a delivery order under 75N93024D00017, an indefinite delivery contract, on Pre-Clinical Models of Infectious Diseases.
Was contract 75N93026F00003 competed?
The extent of competition for 75N93026F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award